Top of the morning to you. Another fine day is unfolding here on the Pharmalot corporate campus, where gray skies are hovering, but our spirits remain sunny. Besides, there is little time to think about the weather with so much to do. We trust you relate. So please join us as we quaffe a needed cup of stimulation and get ready to tackle the to-do list. Meanwhile, here are a few items of interest help you along. Hope your day goes well and you accomplish much. And do stay in touch...
Lilly Lung Cancer Drug Fails Late-Stage Trial (Reuters)
DNA Dark Matter Is Not 'Junk' (Bloomberg News)
FDA Panel Backs Novartis Cystic Fibrosis Drug (Reuters)
FDA Delays Decision On Salix Diarrhea Drug (Bloomberg News)
Alexion And Its $440,000 Drug For A Rare Disorder (Forbes)
FDA Gives Priority Review To J&J TB Treatment (Associated Press)
Chinese Drugmaker Relocates Plant After Pollution Scandal (China Daily)
Targacept To Develop Overactive Bladder Drug (Dow Jones)
Investigators Asked Not To Harass Pharma In Ephedrine Scandal (Express Tribune)
EDITOR'S NOTE: Please check this post for updates during the day
1 Comment